Maria L. Kireeva

机构：Cartesian Therapeutics, Inc. (United States) · ORCID：0000-0003-0527-3182

发表论文 71 篇 · 总被引 5467 次 · h-index 36

代表论文

• Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study (2023 · The Lancet Neurology · 被引 277)
• Complete dissection of transcription elongation reveals slow translocation of RNA polymerase II in a linear ratchet mechanism (2013 · eLife · 被引 144)
• Sensitivity of Mitochondrial Transcription and Resistance of RNA Polymerase II Dependent Nuclear Transcription to Antiviral Ribonucleosides (2012 · PLoS Pathogens · 被引 143)
• Co-transcriptional Assembly of Chemically Modified RNA Nanoparticles Functionalized with siRNAs (2012 · Nano Letters · 被引 127)
• Mechanism of Translesion Transcription by RNA Polymerase II and Its Role in Cellular Resistance to DNA Damage (2012 · Molecular Cell · 被引 127)
• Synergistic action of RNA polymerases in overcoming the nucleosomal barrier (2010 · Nature Structural & Molecular Biology · 被引 125)